GreenBanana SEO celebrates 30th 5-star Google Review, Reinforcing Role as Best Generative Engine Optimization (GEO) Agency 
The Capital Architect Behind the Gala Robots: Shoucheng Holdings (0697.HK) Enters a Milestone Year of Value Re-rating 
Graphene Manufacturing Group and Tickford Racing Unite to Push Performance Efficiency On and Off the Track Spectrum Brands Completes Acquisition of Tristar Products’ Kitchen Appliances and Cookware Business
MIDDLETON, Wis.–(BUSINESS WIRE)–Spectrum Brands Holdings, Inc. (NYSE: SPB; “Spectrum Brands” or the “Company”), a leading…
NerdWallet Announces Conference Call to Review 2021 Fourth Quarter and Full-Year Financial Results
SAN FRANCISCO–(BUSINESS WIRE)–NerdWallet, Inc. (NASDAQ: NRDS), a platform that provides financial guidance to consumers and…
EPR Properties Announces New Board Members and Role Changes on the Board
KANSAS CITY, Mo.–(BUSINESS WIRE)–EPR Properties (NYSE: EPR) today announced that Lisa G. Trimberger and Caixia…
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022
HAMILTON, Bermuda, Feb. 18, 2022 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today…
Capital increase of 360,000 shares in Orphazyme A/S as a result of the utilization of the U.S. At-the-Market Offering Program
Orphazyme A/SCompany announcementNo. 06/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 18, 2022 – Orphazyme A/S…
Meta Ruffy Moves for Another Major Listing: Confirms LBank
New York, New York–(Newsfile Corp. – February 18, 2022) – The Meta Ruffy team has…
OSE Immunotherapeutics Announces Appointment of Alexandre Lebeaut as an Independent Member of the Board of Directors
NANTES, France, Feb. 18, 2022 (GLOBE NEWSWIRE) — OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)…
Adaptive Biotechnologies Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T-Cell Receptors Associated with Crohn’s Disease
Data being presented at the 17th European Crohn’s and Colitis Organisation (ECCO) exhibit the use…
Skill Integrity Council Appoints Honourable William P. Coley II as Executive Director
Las Vegas, Nevada–(Newsfile Corp. – February 18, 2022) – The Skill Integrity Council (the “Council”),…
Energy Transfer LP Files 2021 Annual Report
DALLAS–(BUSINESS WIRE)–Energy Transfer LP (NYSE: ET) today announced it has filed its annual report on…
KBRA Assigns Preliminary Ratings to RRE 11 Loan Management DAC
LONDON–(BUSINESS WIRE)–#KBRA–KBRA UK (KBRA) assigns preliminary ratings to six classes of notes issued by RRE…
Leading Payor CFO Himanshu Shah Joins MedReview
NEW YORK–(BUSINESS WIRE)–MedReview, Inc., a leading provider of payment integrity, utilization management and quality surveillance…
Aizon’s CEO John Vitalie Named One of The Top 25 Biotech CEOs of 2022
SAN FRANCISCO–(BUSINESS WIRE)–#AI–Leading the transformation of BioPharma manufacturing, Aizon’s CEO and Board Member John Vitalie…
DemandTec Named to the Constellation ShortList™ for Price Optimization for Second Year in a Row
Powered by AI, DemandTec Autonomous Pricing enables retailers to maintain price perception and drive profitable…
HFS Ranks Accenture No. 1 Tech Services Provider to Retail and Consumer Packaged Goods Companies
HFS Research noted the “One Accenture” approach that enables Accenture to “bring together its breadth…
Chinook Therapeutics Announces Upcoming Encore Presentations at ISN World Congress of Nephrology 2022
SEATTLE, Feb. 18, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…
Palisade Bio (Nasdaq: PALI) to Present at the Biocom Global Life Science Partnering Conference
CARLSBAD, Calif., Feb. 18, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical…
Clinical Genomics Announces New Publication from Flinders Medical Centre, Highlighting the Use of COLVERA® as a Quantitative ctDNA Biomarker for Response to Colorectal Cancer Therapy
— Article outlines advantages and provides further data to support the use of COLVERA for…
Immutep to Present New Data from the Phase II TACTI-002 Study of Efti at ESMO’s European Lung Cancer Congress 2022
SYDNEY, AUSTRALIA, Feb. 18, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Acerus Announces Amendment to Loan Facilities
Pays off SWK Facility; Reduces Interest Going Forward TORONTO, Feb. 18, 2022 (GLOBE NEWSWIRE) —…